Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR)

NCT: NCT07567027 · RECRUITING

NCT IDNCT07567027
StatusRECRUITING
Start Date2026-06-17
Completion2028-06-01
SponsorNYU Langone Health (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to evaluate the feasibility, safety, and potential protective benefit of Barrigel, a hyaluronic acid-based rectal spacer, in patients undergoing prostate cryoablation for localized or recurrent prostate cancer. The primary aim is to assess Barrigel thermal stability during cryoablation.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑